New cure for leukemia showed high efficiency, increased survival by 90%. Experts say that this drug It may lead to AD end of chemotherapy.
Leukemia Treatment
Chemotherapy is an almost indispensable part of
treatment leukemia . Toxic drugs that a patient receives, kill malignant cells, but at the same time cause and bounce around body. Among the common side effects of chemotherapy loss hair, vomiting, infections, weakness, pain, and depression. Some patients so hard to carry sessions chemistry that even abandon them to "die in peace" without pain.
Leukemia Treatment
Medicament
Ibrutinib He showed incredible effective in the treatment of patients with leukemia - proved their survival better than with chemotherapy. Application
Ibrutinib It helped significantly larger number of patients go into remission, than it was at the chemotherapy. Experts say the drug can make a revolution in treatment of cancer. In addition, he will become the last hope for those patients which develops resistance to chemotherapy.
Studies on 391 patients with chronic lymphocytic leukemia in Melbourne showed that Ibrutinib provides them with survival on at 90%, which is higher than 81%, which occurs during chemotherapy. Medicine less invasive than traditional forms chemistry. Finally, Ibrutinib provided remission during the year to 40% of patients versus only 4% for traditional courses.
Author Dr. Cohn There the Peter MacCallum Cancer Centre on Australia sure Ibrutinib eventually replace chemotherapy business treatment of leukemia . "Maybe the chemistry we do not soon He needs "- smiling doctor. (READ MORE)
Industry News
Go back to the main page
No comments:
Post a Comment